A Collaboration Against COVID-19 (IMAGE)
Caption
A team of scientists led by Matthew Disney, Ph.D., of The Wertheim UF Scripps Institute (center), mapped the druggable pockets (violet, green, red, orange, yellow)of a key RNA from the SARS-CoV-2 virus, its frameshift element, and then designed a potential medicine able to prevent viral replication. Collaborators included Arnab Chatterjee of the Skaggs-Calibr Institute for Innovative Medicines (left) and Sumit Chanda, Ph.D., of Scripps Research (right).
Credit
Illustration by Stacey DeLoye, Cryo-EM model of frameshift RNA by Sandra Kovachka, Ph.D.
Usage Restrictions
For use with news coverage about research from The Wertheim UF Scripps Institute.
License
Original content